Judge Kavanaugh May Be Good US Supreme Court Pick For Pharma

Supreme Court nominee may side with biopharma companies in agency disputes, but it's unclear how he will rule on patent and product liability cases scheduled for review next term.

US Supreme Court building facade with words Equal Justice

It is uncertain what impact President Trump's nomination of Judge Brett Kavanaugh to become the next US Supreme Court justice will have on the biopharmaceutical industry as pharma-related cases that go before the high court do not usually fall along ideological lines.

However, some of Kavanaugh's decisions during his 12 years on the US Court of Appeals for the District of Columbia...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet